Mr Daniel Filipe Inacio Cazeiro
Hospital Santa Maria, Lisbon (Portugal)
SGLT2i on transthyretin amyloid cardiomyopathy - a new drug for an under-recognized cardiomyopathy
Event: Heart Failure 2024
Topic: Pharmacotherapy
Session: ePosters in chronic heart failure - pharmacotherapy 5
Residual pulmonary hypertension after PEA - an ill-defined problem
Event: Heart Failure 2024
Topic: Pulmonary Hypertension
Session: Myocardial disease - clinical 2
Echocardiographic estimation of right atrial pressure in pulmonary hypertension: a reliable tool?
Event: Heart Failure 2024
Topic: Pulmonary Hypertension
Session: Myocardial disease - clinical 2
